Research that Identifies
Undiscovered Value in the MicroCap Market


Trxade Group Email List: Click to Subscribe

View Company Website: Click to View

Market Data: Yahoo Finance, SEC Filings

Report Link: Updated Research Report (Dated 03/15/2018)

Symbol: TRXD
Analyst: Howard Halpern
Taglich Rating: Speculative Buy
Price Target: $0.70
Time Horizon: 12 Months
Rating Established: October 6, 2017
Price When Established: $0.41
Most Recent Report: March 15, 2018
Price When Issued: $0.43

What's New

New information will be posted soon...

Company Description

Trxade Group, Inc., headquartered in Odessa, Florida, owns and operates a supplier-to-pharmacy Web-based marketplace focused on the US pharmaceutical industry. The company’s core service brings the nation’s independent pharmacies and accredited national suppliers of pharmaceuticals together to provide efficient and transparent buying and selling opportunities.

Company Reports

Updated Research Report (Dated 03/15/2018)
Updated Research Report (Dated 11/15/2017)
Initial Research Report (Dated 10/06/2017)


Please view our current disclosure and disclaimer on our most recent research report.